P. A. de Graeff

Rosiglitazone: a European regulatory perspective

E. Blind, Kristina Dunder, P. A. de Graeff et al. · Diabetologia · 2010 · 66 citations · Full text

Medicine, Pharmacovigilance, Pharmacotherapy +4

Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology

Y M Pinto, B. G J L de Smet, Wiek H. van Gilst et al. · Cardiovascular Research · 1993 · 60 citations

Effects of Acetylsalicylic Acid on Peripheral Hemodynamics in Patients with Chronic Heart Failure Treated with Angiotensin-Converting Enzyme Inhibitors

Jan van Wijngaarden, A. J. Smit, P. A. de Graeff et al. · Journal of Cardiovascular Pharmacology · 1994 · 50 citations

Hypertension, Heart Failure, Cardiovascular Pharmacology +18

Potentiation of Isosorbide Dinitrate-Induced Coronary Dilatation by Captopril

Wiek H. van Gilst, P. A. de Graeff, Egbert Scholtens et al. · Journal of Cardiovascular Pharmacology · 1987 · 46 citations

Literary History, Literary Theory, Van Gilst +12

Effects of intravenous captopril on inducible sustained ventricular tachycardia one week after experimental infarction in the anaesthetized pig.

J. H. Kingma, P. A. de Graeff, Wiek H. van Gilst et al. · PubMed · 1986 · 40 citations · Full text